VISTIN PHARMA ASA (VISTN.OL) Stock Overview
OSL:VISTN - NO0010734122 - Common Stock
VISTN.OL Key Statistics, Chart & Performance
The current stock price of VISTN.OL is 23.7 NOK. In the past month the price decreased by -4.9%. In the past year, price decreased by -2.92%.
VISTN.OL Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 1LLY.MI | ELI LILLY & CO | 44.97 | 587.85B | ||
| LLY.DE | ELI LILLY & CO | 44.91 | 586.99B | ||
| ZEG.DE | ASTRAZENECA PLC | 18.48 | 432.52B | ||
| 1JNJ.MI | JOHNSON & JOHNSON | 17.77 | 365.97B | ||
| JNJ.DE | JOHNSON & JOHNSON | 17.74 | 365.35B | ||
| RHO.DE | ROCHE HOLDING AG-BR | 14.75 | 250.06B | ||
| NOT.DE | NOVARTIS AG-REG | 14.84 | 214.61B | ||
| NOV.DE | NOVO NORDISK A/S-B | 13.91 | 206.46B | ||
| SNW.DE | SANOFI | 10.53 | 193.90B | ||
| 1SAN.MI | SANOFI | 10.52 | 193.75B | ||
| SAN.PA | SANOFI | 10.48 | 192.90B | ||
| 6MK.DE | MERCK & CO. INC. | 10.96 | 180.09B |
Related stock screener links
About VISTN.OL
Company Profile
Vistin Pharma ASA is a pharmaceutical company, which engages in the production of Metformin Active Pharmaceutical Ingredients (API). The company is headquartered in Oslo, Oslo. The company went IPO on 2015-06-10. The firm is engaged in the pharmaceuticals industry. The firm is a producer and supplier of Active Pharmaceutical Ingredients (APIs), which are used in medications for diabetes. Vistin Pharma offering such products: Metformin HCl (API); Metformin DC (direct compressible granules); Customized Particle Distribution (PSD) and Premix (Metformin + MgSt, can be delivered on-request). The Company’s customers are pharmaceutical companies worldwide.
Company Info
VISTIN PHARMA ASA
Ostensjoveien 27
Oslo OSLO NO
Employees: 73
Phone: 4748926506
VISTIN PHARMA ASA / VISTN.OL FAQ
What is the stock price of VISTIN PHARMA ASA today?
The current stock price of VISTN.OL is 23.7 NOK. The price increased by 1.72% in the last trading session.
What is the ticker symbol for VISTIN PHARMA ASA stock?
The exchange symbol of VISTIN PHARMA ASA is VISTN and it is listed on the Euronext Oslo exchange.
On which exchange is VISTN.OL stock listed?
VISTN.OL stock is listed on the Euronext Oslo exchange.
What is VISTIN PHARMA ASA worth?
VISTIN PHARMA ASA (VISTN.OL) has a market capitalization of 1.05B NOK. This makes VISTN.OL a Small Cap stock.
How many employees does VISTIN PHARMA ASA have?
VISTIN PHARMA ASA (VISTN.OL) currently has 73 employees.
What are the support and resistance levels for VISTIN PHARMA ASA (VISTN.OL) stock?
VISTIN PHARMA ASA (VISTN.OL) has a support level at 22.6 and a resistance level at 23.5. Check the full technical report for a detailed analysis of VISTN.OL support and resistance levels.
Should I buy VISTIN PHARMA ASA (VISTN.OL) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of VISTN.OL, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of VISTN.OL, evaluating the profitability, health, valuation and growth aspects
- VISTIN PHARMA ASA (VISTN.OL) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- VISTIN PHARMA ASA (VISTN.OL) Sales and EPS estimates to see what analysts future expectations are.
- VISTIN PHARMA ASA (VISTN.OL) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- VISTIN PHARMA ASA (VISTN.OL) Insider and Institutional Ownership to learn about the owners and their transactions.
- VISTIN PHARMA ASA (VISTN.OL) Stock Chart to make your own analysis
- VISTIN PHARMA ASA (VISTN.OL) Latest news and press-releases to stay up to date.
Does VISTIN PHARMA ASA (VISTN.OL) stock pay dividends?
VISTIN PHARMA ASA (VISTN.OL) has a dividend yield of 5.32%. The yearly dividend amount is currently 0. Check the full fundamental report for a detailed analysis of VISTN.OL dividend history, reliability and sustainability.
When does VISTIN PHARMA ASA (VISTN.OL) report earnings?
VISTIN PHARMA ASA (VISTN.OL) will report earnings on 2025-10-31.
What is the Price/Earnings (PE) ratio of VISTIN PHARMA ASA (VISTN.OL)?
The PE ratio for VISTIN PHARMA ASA (VISTN.OL) is 13.7. This is based on the reported non-GAAP earnings per share of 1.73 and the current share price of 23.7 NOK. Check the full fundamental report for a full analysis of the valuation metrics for VISTN.OL.
VISTN.OL Technical Analysis
VISTN.OL Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to VISTN.OL. VISTN.OL is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average.
VISTN.OL Financial Highlights
Over the last trailing twelve months VISTN.OL reported a non-GAAP Earnings per Share(EPS) of 1.73. The EPS increased by 36.54% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 17.44% | ||
| ROA | 18.66% | ||
| ROE | 23.18% | ||
| Debt/Equity | 0 |